ArticleBMJ global health2020
The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model.
Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 152 citations in OpenAlex.
- Epidemics, Lockdown Measures and Vulnerable Populations: A Mixed-Methods Systematic Review of the Evidence of Impacts on Mother and Child Health in Low-and Lower-Middle-Income Countries.International journal of health policy and management · 2022Pooled it
- Infectious disease modelling for SARS-CoV-2 in Africa to guide policy: A systematic review.Epidemics · 2022Pooled it
- Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.Journal of medical virology · 2021Pooled it
- Life Course Malaria Exposure and SARS-CoV-2 Seroepidemiology in Ugandan Adolescents: A Longitudinal Study Nested in a Birth Cohort.Tropical medicine & international health : TM & IH · 2026Article
- Article
- Transforming the African public health systems towards the achievement of universal health coverage and global health security.BMJ public health · 2026Article
- Characterizing acute and persistent symptoms of COVID-19 among adults and children in rural Zambia, 2020-2022.PLOS global public health · 2026Article
- How can timeliness and accuracy be balanced? The surveillance information reporting mechanism for public health emergencies based on the online direct reporting system.BMC public health · 2025Article
- Characteristics, management and factors associated with poor outcomes in COVID-19 patients in Burkina Faso: insights from a 2021 large-scale ambispective study.Frontiers in public health · 2025Observational
- Knowledge, attitudes and acceptance of COVID-19 vaccine among pregnant women in Mbeya Region.PLOS global public health · 2025Article
- Design, Synthesis and Biological Exploration of NovelInternational journal of molecular sciences · 2024Article
- Article
- Controlling the first wave of the COVID-19 pandemic in Malawi: Results from a multi-round study.PLOS global public health · 2024Article
- COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey.BMC infectious diseases · 2023Article
- Dynamics of factors associated with rates of COVID-19 cases and deaths in African countries.Globalization and health · 2023Article
- Conflicting COVID-19 excess mortality estimates.Lancet (London, England) · 2023Article
- Out-of-Hospital Cardiac Arrest during the COVID-19 Pandemic: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?Open research Africa · 2023Article
- The first year of the COVID-19 pandemic in the ECOWAS region.Ghana medical journal · 2022Article
- Developing forecasting capacity for public health emergency management in Africa using syndemics approach: lessons from the COVID-19 pandemic.BMJ global health · 2022Article
14 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been unprecedented in its speed and effects. Interruption of its transmission to prevent widespread community transmission is critical because its effects go beyond the number of COVID-19 cases and deaths and affect the health system capacity to provide other essential services. Highlighting the implications of such a situation, the predictions presented here are derived using a Markov chain model, with the transition states and country specific probabilities derived based on currently available knowledge. A risk of exposure, and vulnerability index are used to make the probabilities country specific. The results predict a high risk of exposure in states of small size, together with Algeria, South Africa and Cameroon. Nigeria will have the largest number of infections, followed by Algeria and South Africa. Mauritania would have the fewest cases, followed by Seychelles and Eritrea. Per capita, Mauritius, Seychelles and Equatorial Guinea would have the highest proportion of their population affected, while Niger, Mauritania and Chad would have the lowest. Of the World Health Organization's 1 billion population in Africa, 22% (16%-26%) will be infected in the first year, with 37 (29 - 44) million symptomatic cases and 150 078 (82 735-189 579) deaths. There will be an estimated 4.6 (3.6-5.5) million COVID-19 hospitalisations, of which 139 521 (81 876-167 044) would be severe cases requiring oxygen, and 89 043 (52 253-106 599) critical cases requiring breathing support. The needed mitigation measures would significantly strain health system capacities, particularly for secondary and tertiary services, while many cases may pass undetected in primary care facilities due to weak diagnostic capacity and non-specific symptoms. The effect of avoiding widespread and sustained community transmission of SARS-CoV-2 is significant, and most likely outweighs any costs of preventing such a scenario. Effective containment measures should be promoted in all countries to best manage the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.